NIMOTUZUMAB
UNII 6NS400BXKH

Substance Identification & Data

This profile provides standardized clinical and technical data for Nimotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6NS400BXKH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 780758-10-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6NS400BXKH

CAS Registry Number

780758-10-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NIMOTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2733

National Cancer Institute reference terminology for clinical and research data.

INN ID

8545

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nimotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NIMOTUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULPHIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER

NIMOTUZUMAB [INN]

NIMOTUZUMAB [MI]

NIMOTUZUMAB [WHO-DD]